Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Albuterol delivery during noninvasive ventilation.

Matthew P Branconnier1, Dean R Hess

  • 1Department of Respiratory Care, Massachusetts General Hospital, Boston, 02114, USA.

Respiratory Care
|December 2, 2005
PubMed
Summary

Albuterol delivery via nebulizer or metered-dose inhaler (MDI) during noninvasive ventilation depends on device type, leak port location, and MDI actuation timing for optimal patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-Ventilator Interaction During Noninvasive Ventilation.

Respiratory care·2025
Same author

Maximizing Extubation Outcomes Through Educational and Organizational Research (METEOR) Trial: protocol for a batched, stepped-wedge, cluster-randomised, type 2 hybrid effectiveness-implementation trial.

BMJ open·2025
Same author

Author Response: Let It Breathe: Mastering Spontaneous Breathing Trials.

Respiratory care·2024
Same author

AARC Clinical Practice Guideline: Patient-Ventilator Assessment.

Respiratory care·2024
Same author

Pulse Oximetry: 2023 Year in Review.

Respiratory care·2024
Same author

Statistics for the Non-Statistician: How to Read the Respiratory Care Literature.

Respiratory care·2024

Area of Science:

  • Respiratory Medicine
  • Pharmacology
  • Biomedical Engineering

Background:

  • Optimizing albuterol delivery during noninvasive positive-pressure ventilation (NIPPV) is crucial for managing respiratory conditions.
  • The efficiency of aerosolized medication delivery can be influenced by various factors within the NIPPV circuit.

Purpose of the Study:

  • To investigate the impact of different aerosol delivery devices (nebulizer vs. metered-dose inhaler [MDI]) on albuterol delivery during NIPPV.
  • To evaluate how the location of the leak port (in the circuit vs. in the mask) affects albuterol deposition.
  • To determine the influence of MDI actuation timing (inspiratory vs. expiratory) on drug delivery efficiency.

Main Methods:

  • A lung model simulating spontaneous breathing was used with a bi-level positive airway pressure ventilator.
  • Two mask types with different leak port locations were tested.
  • Albuterol delivery was assessed using both a nebulizer and an MDI, with the MDI actuated either during inhalation or exhalation.

Main Results:

  • Nebulizer delivery resulted in more albuterol deposition when the leak port was in the circuit.
  • Overall, nebulizer delivery was more efficient than MDI delivery.
  • Albuterol delivery efficiency was comparable between nebulizer and MDI when the leak port was in the circuit, but superior with MDI when the leak port was in the mask.
  • MDI actuation during exhalation significantly reduced albuterol delivery.

Conclusions:

  • Albuterol delivery during NIPPV is significantly influenced by the choice of aerosol device.
  • The placement of the leak port in the ventilation circuit or mask critically affects drug delivery.
  • Proper timing of MDI actuation within the respiratory cycle is essential for maximizing albuterol deposition.

Related Experiment Videos